Biology and management of AIDS-associated non-Hodgkin's lymphoma

被引：17

作者：

Gates, AE

Kaplan, LD

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Positive Hlth Program, San Francisco, CA 94110 USA

[2] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(03)00041-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The introduction of highly active antiretroviral therapy has affected the epidemiology and treatment of HIV-related lymphomas. Improved immune function has made the use of standard-dose chemotherapy possible in this population. Therapies once reserved for HIV-negative patients-such as immunotherapy and high-dose chemotherapy with either autologous or allogeneic stem cell transplantation-are undergoing active investigation in HIV-positive patients with lymphoma. It remains unclear whether the use of combination chemotherapy and antiretroviral therapy will result in improved outcomes.

引用

页码：821 / +

页数：22

共 100 条

[21]

2-X

[22]

DEAN M, 1999, CANCER RES, P3561

[23]

Deangelis L M, 1995, Oncology (Williston Park), V9, P63

[24]

DeMario MD, 1998, SEMIN ONCOL, V25, P492